Cervical and Thoracic Myelopathy
Cervical and Thoracic Myelopathy is a research topic within Surgery. Science Explorer counts 28k research works in it since 1951. 15.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on various surgical interventions and complications related to the cervical spine, including anterior cervical discectomy, fusion, myelopathy, degenerative disc disease, adjacent segment degeneration, dysphagia, cervical arthroplasty, laminoplasty, and ossification of the posterior longitudinal ligament.
- Cervical Spine Surgery
- Anterior Cervical Discectomy
- Cervical Fusion
- Myelopathy
- Degenerative Disc Disease
- Adjacent Segment Degeneration
- Dysphagia
- Cervical Arthroplasty
- Laminoplasty
- Ossification of Posterior Longitudinal Ligament
- Research works
- 28k fractional, since 1951
- In the world top 10%
- 4.3k per year above
- Top-10% rate
- 15.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +26% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cervical and Thoracic Myelopathy research?
By volume, the United States and China publish the most (1.5k and 1.5k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.5k works
- 2 China 1.5k works
- 3 Japan 393 works
- 4 South Korea 314 works
- 5 India 268 works
- 6 Germany 167 works
- 7 Türkiye 140 works
- 8 United Kingdom 138 works
- 9 Italy 127 works
- 10 Canada 124 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cervical and Thoracic Myelopathy research?
By volume in 2022–2025, Neurological Surgery publishes the most Cervical and Thoracic Myelopathy research, followed by Capital Medical University and Hospital for Special Surgery.
By volume, 2022–2025
- 1 Neurological SurgeryUnited States 49 works
- 2 Capital Medical UniversityChina 46 works
- 3 Hospital for Special SurgeryUnited States 41 works
- 4 Rush University Medical CenterUnited States 38 works
- 5 Peking UniversityChina 32 works
- 6 Sichuan UniversityChina 29 works
- 7 West China Hospital of Sichuan UniversityChina 27 works
- 8 Shanghai Changzheng HospitalChina 21 works
- 9 Wooridul HospitalSouth Korea 20 works
- 10 Brown UniversityUnited States 19 works
Who are the leading researchers in Cervical and Thoracic Myelopathy?
The most-cited researchers publishing on Cervical and Thoracic Myelopathy include Frederik Barkhof.
- 1 Frederik Barkhof Netherlands 2.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cervical and Thoracic Myelopathy research done?
The largest centres of Cervical and Thoracic Myelopathy research in 2022–2025 are Beijing (China), Seoul (South Korea), New York (United States) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Rockville Centre and Phoenix.
Largest cities, 2022–2025
Where it is the local speciality
- Rockville CentreUS · 48.6 works59×
- PhoenixUS · 26.5 works15×
Location quotient: how much more of its research is in Cervical and Thoracic Myelopathy than the world average.
Where is the best place to study Cervical and Thoracic Myelopathy?
Among universities, judged by research, Capital Medical University, Brown University and Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Capital Medical UniversityChina | 68.9 | 17.8% | 14.2× | 46 | +99.6% |
| 2 | Brown UniversityUnited States | 66.3 | 21.1% | 8.7× | 19 | +267.0% |
| 3 | Icahn School of Medicine at Mount SinaiUnited States | 59.7 | 19.8% | 6.7× | 18 | +232.2% |
| 4 | Catholic University of KoreaSouth Korea | 58.1 | 19.6% | 10.1× | 10 | +142.7% |
| 5 | University of ZurichSwitzerland | 55.6 | 36.0% | 3.6× | 11 | +73.5% |
| 6 | Dalian Medical UniversityChina | 54.6 | 21.4% | 8.4× | 9 | +200.6% |
| 7 | Thomas Jefferson UniversityUnited States | 54.4 | 22.4% | 13.9× | 15 | -2.9% |
| 8 | Zhejiang Chinese Medical UniversityChina | 53.5 | 28.7% | 8.9× | 13 | +21.9% |
| 9 | Chengdu University of Traditional Chinese MedicineChina | 51.6 | 30.2% | 8.0× | 10 | — |
| 10 | Cornell UniversityUnited States | 51.1 | 32.4% | 3.2× | 18 | +41.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cervical and Thoracic Myelopathy research growing?
Output in 2018–2022 was 26% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cervical and Thoracic Myelopathy.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.